| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3118fd7c30984d605a56c2c8ab1dcfbf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate |
2019-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ac45f5983dc5880b731204cf7433e11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2da8fcd2faba58744f30436f2cef868e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7647bbeb5de6b52bf81544b0036b80f4 |
| publicationDate |
2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019169029-A1 |
| titleOfInvention |
Target specific chemotherapeutic agents |
| abstract |
This invention is directed to chemotherapeutic conjugates comprising a targeting agent and a chemotherapeutic agent where, in one embodiment, the targeting agent is folic acid and the chemotherapeutic agent is an amino acid mimetic. |
| priorityDate |
2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |